Lamond Capital Partners LLC
Follow13F filer, CIK 1542550, SAN FRANCISCO, CA
Lamond Capital Partners LLC reported $14,280,000 across 1 holding for the quarter ended 2016-03-31, in a 13F-HR filed 2016-05-05.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001542550-16-000010
- Period
- 2016-03-31
- Reported value
- $14.3M
- Holdings
- 1
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 6
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ORCLexited | -500,000 | -$18.3M |
| PBYIexited | -220,780 | -$17.3M |
| AMGNexited | -75,000 | -$12.2M |
| ABBVreduced | -50,000 | -$2.86M |
| IGNYTA INCexited | -46,721 | -$626K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2016
Share positions as resolved from 13F-HR 0001542550-16-000010, largest first. % of portfolio is the value over $14,280,000, the sum of the share positions whose value is usable for ratios (method).
Sold out in Q1 2016
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ORCLORACLE CORP | 500,000 | $18.3M | shares |
| PBYIPUMA BIOTECHNOLOGY INC | 220,780 | $17.3M | shares |
| AMGNAMGEN INC | 75,000 | $12.2M | shares |
| IGNYTA INCIGNYTA INC | 46,721 | $626K | shares |
| ZELTIQ AESTHETICS INCZELTIQ AESTHETICS INC | 16,119 | $460K | shares |
| IMMUNOMEDICS INCIMMUNOMEDICS INC | 100,000 | $307K | shares |
How Q1 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001542550-16-000010 | base | 2016-05-05 | acceptance time not in the bulk data set |